GOV. FERGUSON SIGNS TEAMSTERS-BACKED BILL SECURING UI BENEFITS FOR STRIKING WORKERS
OLYMPIA, Wash., May 20, 2025 /PRNewswire/ -- Teamsters-backed legislation that will extend unemployment insurance (UI) to workers on strike has been signed into law by Governor Bob Ferguson.
"This is a major victory. This law will ensure striking workers don't have to choose between fighting for their rights and feeding their families," said Rick Hicks, President of Teamsters Joint Council 28. "Strikes are always a last resort, and employers cause them by demanding unreasonable concessions from workers. This law protects not just union members, but the entire bargaining process."
With the passage of SB 5041, Washington has joined New York and New Jersey to become the third state in the nation to extend unemployment insurance to striking workers.
"We're leveling the playing field and giving workers the strength to fight for fair contracts even if they get forced to the picket line by their employers," said Paul Dascher, Secretary-Treasurer of Teamsters Local 117. "This bill happened because Teamsters came together and demonstrated the same strength and solidarity in the halls of the state house that we demonstrate on the picket lines. Washington State is leading the way in protecting and enhancing workers' rights, and Teamsters are making that happen."
Teamsters Joint Council 28 represents workers in a wide variety of industries throughout Washington, Alaska, and the Idaho Panhandle. For more information, visit jc28.org.
Contact: Matt McQuaid, (771) 241-0015mmcquaid@teamster.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/gov-ferguson-signs-teamsters-backed-bill-securing-ui-benefits-for-striking-workers-302461168.html
SOURCE Teamsters Joint Council 28
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
MARS Company Announces VEROflow Mobile App: Revolutionizing Meter Field Testing for Water Municipalities
Advanced Mobile Technology for Precision, Efficiency, and Compliance in the Field OCALA, Fla., June 9, 2025 /PRNewswire/ -- MARS Company, a recognized leading innovator in flow measurement and water meter testing accuracy solutions, is excited to announce the release of the VEROflow Mobile Tester App, the ultimate mobile companion for the VEROflow-4 Field Testing Unit. Designed specifically for water municipalities, this cutting-edge app streamlines large meter testing, making it a seamless, accurate, and efficient process. It empowers field technicians to achieve operational excellence while ensuring compliance with industry standards. The VEROflow Mobile Tester App, now available on the App Store for iOS devices (version 16.0 or later), integrates advanced features with an intuitive interface to meet the demands of modern field testing. Optimized for iPhone and iPad, this app delivers unmatched functionality with secure local data storage, making it an indispensable tool for water management professionals. Key Features and Benefits: Smart OCR Meter Recognition: Automatically captures meter readings, serial numbers, and more with intelligent value extraction—just snap a photo, and the app does the rest. MARS AI Chat: Offers instant support with an intelligent AI assistant, providing answers on app usage, best practices, and step-by-step guidance for VEROflow-4 hardware. Advanced Geolocation Integration: Leverages GPS tracking, Google Maps integration, and reverse address lookup to document the precise location of each test. Comprehensive Analytics Dashboard: Provides real-time insights with customizable charts (line, bar, scatter) to track accuracy and visualize trends. Comprehensive Reporting and Test History: Access searchable test records with chronological tracking, exportable as PDF or CSV reports, and share directly from your iPhone via email or other apps. Seamless iOS Integration and Offline Capability: Works flawlessly on iPhone and iPad, with full offline functionality that stores all data locally for maximum security. "The VEROflow Mobile Tester App is a game-changer for water municipalities performing in-field large meter testing," said Dave Corey, CEO at MARS Company. "By combining precision technology with a user-centric design, we're empowering field technicians to test smarter, work faster, and ensure compliance—all while keeping their data secure. This app is the future of in-field large meter testing." Available now on the Apple App Store, the VEROflow Mobile Tester App is the go-to solution for water municipalities looking to streamline their field-testing operations. Download today and pair with your VEROflow-4 Field Testing Unit to experience unparalleled precision and efficiency. MARS Company will exhibit at the AWWA ACE25 Trade show from June 9th – 11th, 2025, in Denver, Colorado, at booth #3344. For more information about this innovative solution and how it can revolutionize your meter testing process, please visit our website at or contact our sales team at sales@ About MARS CompanyAs the global leader in water meter measurement for sustainable revenue recovery, MARS Company continues to innovate and transform the water meter measurement industry worldwide through the unparalleled design, development, and manufacturing of patented analytical enterprise software and ultra-high-precision measurement equipment. Whether the test bench solutions or enterprise software systems, each offering from MARS provides customers with state-of-the-art business intelligence, powerful data visualization, and highly advanced solutions to some of the most common yet costly water management issues. CONTACT: Jeff Butt, Vice President of Operations; Tel: (813) 466-9808, 396411@ This press release contains forward-looking statements, including statements containing the words "planned," "expects," "believes," "strategy," "opportunity," "anticipates," and similar words. Such forward-looking statements are subject to known and unknown risks, uncertainties or other factors that may cause MARS Company's actual results to be materially different from historical results or any results expressed or implied by such forward-looking statements. MARS Company assumes no obligation to update any forward-looking statements to reflect events or circumstances arising after the date hereof. The potential risks and uncertainties which could cause actual growth and results to differ materially include but are not limited to, customer acceptance of the company's services, products and fee structures, the success of the company's brand development efforts, the volatile and competitive nature of the water industry, and changes in domestic and international market conditions, and foreign exchange rates. View original content to download multimedia: SOURCE MARS Company
Yahoo
24 minutes ago
- Yahoo
GELITA Showcases Advanced Excipient Solutions at BIO International- June 2025 in Boston
EBERBACH, Germany, June 9, 2025 /PRNewswire/ -- GELITA, a global leader in pharmaceutical gelatin and collagen peptide solutions, is proud to announce its participation as an exhibitor at BIO International 2025 in Boston. This year's presentation highlights the company's innovative excipients, MEDELLAPRO® and VACCIPRO®, meeting the specific needs of advanced pharmaceutical formulations and medical devices. GELITA's Endotoxin Controlled Excipients (ECE) portfolio, including MEDELLAPRO® (gelatin) and VACCIPRO® (collagen peptides), addresses the demanding requirements of pharmaceutical and medical applications such as vaccine stabilizers, tissue engineering, 3D bioprinting, implants and advanced wound care. In pharmaceutical, medical device and healthcare environments, endotoxin control is crucial to ensure product safety and patient well-being. MEDELLAPRO® stands out for its versatility and inherent biocompatibility, making it ideal for applications such as surgical sealants, hemostatic agents, scaffolds, 3D bioprinting and drug delivery systems. Vaccines stabilized with VACCIPRO® show very low allergenic potential, high bioavailability and excellent cell tissue affinity. VACCIPRO® is globally recognized as THE gold standard by vaccine manufacturers. With a strong commitment to quality and innovation, GELITA continues to empower the pharmaceutical and medical device industries with solutions that drive efficiency and safety in the development of life-saving therapies. GELITA is well advanced in developing biotechnological processes to produce animal-free alternatives with optimized properties that are even more resource-efficient and sustainable than conventional methods. With the pharmaceutical know-how of the GELITA Pharma Institute and GELITA's Biotech R&D Hub, the company is well-equipped to expand its biotechnological expertise and product portfolio Visit GELITA at Booth 2865-01in the German Pavilion to explore how MEDELLAPRO® and VACCIPRO® are shaping the future of vaccine development and medical devices. About GELITA GELITA is one of the leading companies for manufacturing and marketing collagen proteins. Coordinated from headquarters in Eberbach, Germany, GELITA provides customers around the world with products of the highest standard, comprehensive technical expertise and sophisticated solutions. More than 20 sites and a global expert network ensure that state-of-the-art know-how is always available for customers. GELITA's performance is based on 150 years of experience in the field of collagen proteins, and a strong desire for innovation is the driving force of the family-owned company, which is always looking for new solutions for food, pharmaceutical, health & nutrition markets, as well as for technical applications. Within its range of collagen proteins, GELITA supplies collagen peptides with proven body-stimulating capabilities as well as tailor-made gelatins. This holistic range of products in combination with its vast experience in developing solutions for different applications makes GELITA first choice for customers in every continent. In today's landscape of high consumer demands, manufacturers of food products must rely on natural, healthy, non-allergenic ingredients for successful developments. Collagen proteins from GELITA are the perfect match for this as they fulfill all these requirements, a particular plus being the fact that they are foodstuffs (i.e. no E-number). Media Contact: Amy Maggio 396407@ 312-617-6248 Company Contact: Martin Junginger (Senior Expert Global Category Management Pharma & Bioscience)GELITA AG +49 6271 84 2103 396407@ View original content to download multimedia: SOURCE GELITA Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
A SAFE RAW MILK BREAKTHROUGH: TAMARACK BIOTICS EARNS FDA ACCEPTANCE OF INNOVATIVE TREATMENT
FRESNO, Calif., June 9, 2025 /PRNewswire/ -- In an historic milestone for food safety and nutrition, Tamarack Biotics secured U.S. FDA acceptance for its novel light-based milk treatment process. This clears the way for a new generation of dairy products that retain the full bioactive benefits of raw milk without the risk. Using advanced UV light technology, Tamarack's TruActive® process eliminates harmful pathogens while preserving the enzymes, proteins and immunity-supporting compounds that are often destroyed by traditional heat-based pasteurization. The result is a scientifically verified, safe, raw milk equivalent—a first in the dairy industry and an exciting development for the growing public demand for raw and minimally processed foods. This is not simply another method of pasteurization, which has been normalized with its heat-based treatment for decades. Tamarack Biotic's light-focusing treatment preserves the taste and creaminess of raw milk, which a growing number of people have rediscovered. Tamarack's TruActive® process is also more sustainable than thermal processing—far less energy is used. "Safe treatment of milk hasn't fundamentally changed in over 150 years," said Bob Comstock, CEO of Tamarack Biotics. "We've created a solution that brings raw milk safety into the 21st century, without sacrificing what makes milk truly nutritious. Our UV process actually achieves a greater level of safety than thermal pasteurization, which is truly remarkable." The FDA's determination confirms that Tamarack's method meets the official efficacy criteria for pasteurization, allowing it to initially be used in the production of powdered dairy ingredients such as whey protein concentrate, milk protein concentrate and immune-supporting compounds like lactoferrin. Tamarack has already started expanding TruActive® to other dairy products such as cheese, yogurt, kefir and colostrum. These steps pave the way for acceptance of TruActive® treatment of liquid raw milk as early as 2027. A UC Davis clinical trial demonstrated that a milk protein concentrate treated with the TruActive® process restored immune function in aging populations. Additionally, many European studies proved that raw milk consumption protected children from developing allergies such as asthma, eczema and food allergies. Tamarack's light-based system delivers the compounds believed responsible for allergy protection with none of the risks associated with unpasteurized dairy. Tamarack Biotics is a food technology company developing science-backed, non-thermal methods to safely treat milk without compromising natural health benefits. Media Contact:Vikaas Shankervikaas@ 730-6941 View original content: SOURCE Tamarack Biotics
